emedastine has been researched along with Hay Fever in 3 studies
emedastine: structure given in first source
emedastine : 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The emedastine patch was developed in Japan as the first transdermal drug delivery system of emedastine difumarate for allergic rhinitis." | 2.87 | Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinit ( Akiyama, K; Kobayashi, S; Okubo, K; Tanaka, Y; Terahara, T; Uchida, E, 2018) |
| "Emedastine is a new H1-receptor antagonist endowed with potent and selective antihistamine activity." | 2.71 | Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis. ( Assandri, A; Corrado, ME; Hartwig, J; Mion, A; Oldeman, HG; Radicioni, MM, 2004) |
| " Safety was assessed on routine laboratory assays and recording vital signs and adverse events (AEs)." | 2.71 | Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis. ( Assandri, A; Corrado, ME; Horak, F; Kavina, A; Mion, A; Stübner, P; Zieglmayer, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okubo, K | 1 |
| Uchida, E | 1 |
| Terahara, T | 1 |
| Akiyama, K | 1 |
| Kobayashi, S | 1 |
| Tanaka, Y | 1 |
| Corrado, ME | 2 |
| Radicioni, MM | 1 |
| Hartwig, J | 1 |
| Assandri, A | 2 |
| Oldeman, HG | 1 |
| Mion, A | 2 |
| Horak, F | 1 |
| Stübner, P | 1 |
| Zieglmayer, R | 1 |
| Kavina, A | 1 |
3 trials available for emedastine and Hay Fever
| Article | Year |
|---|---|
Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinit
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Benzimidazoles; Double-Blind Method; Female; Humans; | 2018 |
Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Fe | 2004 |
Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Cross-Over Studies; Double-Blin | 2004 |